These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, Liu P, Eells PL, Griebel J, Baier M, Kinsella JP, Abman SH. J Pediatr; 1999 Apr; 134(4):406-12. PubMed ID: 10190913 [Abstract] [Full Text] [Related]
38. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Heeney MM, Abboud MR, Amilon C, Andersson M, Githanga J, Inusa B, Kanter J, Leonsson-Zachrisson M, Michelson AD, Berggren AR, HESTIA3 study investigators. Contemp Clin Trials; 2019 Oct; 85():105835. PubMed ID: 31446143 [Abstract] [Full Text] [Related]
39. Multicenter randomized controlled trial of inhaled nitric oxide for pediatric acute respiratory distress syndrome. Bronicki RA, Fortenberry J, Schreiber M, Checchia PA, Anas NG. J Pediatr; 2015 Feb; 166(2):365-9.e1. PubMed ID: 25454942 [Abstract] [Full Text] [Related]
40. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Badaki-Makun O, Scott JP, Panepinto JA, Casper TC, Hillery CA, Dean JM, Brousseau DC, Pediatric Emergency Care Applied Research Network (PECARN) Magnesium in Sickle Cell Crisis (MAGiC) Study Group. Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]